Literature DB >> 23264068

Outcome impact of goal directed fluid therapy during high risk abdominal surgery in low to moderate risk patients: a randomized controlled trial.

Davinder S Ramsingh1, Chirag Sanghvi, Joseph Gamboa, Maxime Cannesson, Richard L Applegate.   

Abstract

Intraoperative goal directed fluid therapy (GDT) guided by an arterial pressure-based cardiac output system has been reported to improve gastrointestinal (GI) recovery in high-risk patients. This study evaluates the impact of this approach on GI recovery in low to moderate risk patients undergoing major abdominal surgery. IRB approved randomized controlled trial in low to moderate risk adults scheduled for major surgery. Patients were randomized to standard (n = 20) or GDT (n = 18) groups, whose fluids were managed to maintain stroke volume variation (SVV) <12 %. The primary outcome measure was GI recovery. Additional measures included quality of recovery score. Continuous, non-normally distributed by Mann-Whitney test; ordinal and nominal by Chi square analysis. GDT patients had lower average intraoperative SVV. The GDT group had faster return of GI function (p = 0.004) and higher quality of recovery scores. In low to moderate risk patients undergoing major abdominal surgery, intraoperative GDT guided by SVV optimization was associated with faster restoration of GI recovery and higher quality of recovery scores. These results suggest that outcome benefits related to the use of an intraoperative goal directed fluid protocol guided by SVV are not limited to high-risk patients.

Entities:  

Mesh:

Year:  2012        PMID: 23264068     DOI: 10.1007/s10877-012-9422-5

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  36 in total

Review 1.  Changes in arterial pressure during mechanical ventilation.

Authors:  Frédéric Michard
Journal:  Anesthesiology       Date:  2005-08       Impact factor: 7.892

2.  POSSUM and Portsmouth POSSUM for predicting mortality. Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity.

Authors:  D R Prytherch; M S Whiteley; B Higgins; P C Weaver; W G Prout; S J Powell
Journal:  Br J Surg       Date:  1998-09       Impact factor: 6.939

3.  Randomized controlled trial of intraoperative goal-directed fluid therapy in aerobically fit and unfit patients having major colorectal surgery.

Authors:  C Challand; R Struthers; J R Sneyd; P D Erasmus; N Mellor; K B Hosie; G Minto
Journal:  Br J Anaesth       Date:  2011-08-26       Impact factor: 9.166

Review 4.  Arterial pressure variation and goal-directed fluid therapy.

Authors:  Maxime Cannesson
Journal:  J Cardiothorac Vasc Anesth       Date:  2010-06       Impact factor: 2.628

5.  Risk adjustment as basis for rational benchmarking: the example of colon carcinoma.

Authors:  Henry Ptok; Frank Marusch; Uwe Schmidt; Ingo Gastinger; Hubertus J C Wenisch; Hans Lippert
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

Review 6.  Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares.

Authors:  Paul E Marik; Michael Baram; Bobbak Vahid
Journal:  Chest       Date:  2008-07       Impact factor: 9.410

7.  Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery.

Authors:  Tong J Gan; Andrew Soppitt; Mohamed Maroof; Habib el-Moalem; Kerri M Robertson; Eugene Moretti; Peter Dwane; Peter S A Glass
Journal:  Anesthesiology       Date:  2002-10       Impact factor: 7.892

8.  Occult hypoperfusion and mortality in patients with suspected infection.

Authors:  Michael D Howell; Michael Donnino; Peter Clardy; Daniel Talmor; Nathan I Shapiro
Journal:  Intensive Care Med       Date:  2007-07-06       Impact factor: 17.440

9.  Variations in arterial blood pressure are associated with parallel changes in FlowTrac/Vigileo-derived cardiac output measurements: a prospective comparison study.

Authors:  Savvas Eleftheriadis; Zisis Galatoudis; Vasilios Didilis; Ioannis Bougioukas; Julika Schön; Hermann Heinze; Klaus-Ulrich Berger; Matthias Heringlake
Journal:  Crit Care       Date:  2009-11-09       Impact factor: 9.097

10.  Goal-directed fluid management based on pulse pressure variation monitoring during high-risk surgery: a pilot randomized controlled trial.

Authors:  Marcel R Lopes; Marcos A Oliveira; Vanessa Oliveira S Pereira; Ivaneide Paula B Lemos; Jose Otavio C Auler; Frédéric Michard
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  29 in total

1.  Reliability of a new 4th generation FloTrac algorithm to track cardiac output changes in patients receiving phenylephrine.

Authors:  Fuhai Ji; Jian Li; Neal Fleming; David Rose; Hong Liu
Journal:  J Clin Monit Comput       Date:  2014-09-30       Impact factor: 2.502

2.  Association of conflicts of interest with the results and conclusions of goal-directed hemodynamic therapy research: a systematic review with meta-analysis.

Authors:  Lina Zhang; Feng Dai; Alexandria Brackett; Yuhang Ai; Lingzhong Meng
Journal:  Intensive Care Med       Date:  2018-08-13       Impact factor: 17.440

3.  Goal-directed versus Standard Fluid Therapy to Decrease Ileus after Open Radical Cystectomy: A Prospective Randomized Controlled Trial.

Authors:  Vittoria Arslan-Carlon; Kay See Tan; Guido Dalbagni; Alessia C Pedoto; Harry W Herr; Bernard H Bochner; Eugene K Cha; Timothy F Donahue; Mary Fischer; S Machele Donat
Journal:  Anesthesiology       Date:  2020-08       Impact factor: 7.892

Review 4.  Applied physiology at the bedside to drive resuscitation algorithms.

Authors:  Andre L Holder; Michael R Pinsky
Journal:  J Cardiothorac Vasc Anesth       Date:  2014-12       Impact factor: 2.628

5.  Pre-anesthetic stroke volume variation can predict cardiac output decrease and hypotension during induction of general anesthesia.

Authors:  Takashi Juri; Koichi Suehiro; Sayaka Tsujimoto; Shigemune Kuwata; Akira Mukai; Katsuaki Tanaka; Tokuhiro Yamada; Takashi Mori; Kiyonobu Nishikawa
Journal:  J Clin Monit Comput       Date:  2017-06-24       Impact factor: 2.502

6.  Optimal Perioperative Fluid Therapy Associates with Fewer Complications After Pancreaticoduodenectomy.

Authors:  Piia Peltoniemi; Pertti Pere; Harri Mustonen; Hanna Seppänen
Journal:  J Gastrointest Surg       Date:  2022-09-21       Impact factor: 3.267

7.  Monitoring of pulse pressure variation using a new smartphone application (Capstesia) versus stroke volume variation using an uncalibrated pulse wave analysis monitor: a clinical decision making study during major abdominal surgery.

Authors:  Alexandre Joosten; Alexandra Jacobs; Olivier Desebbe; Jean-Louis Vincent; Saxena Sarah; Joseph Rinehart; Luc Van Obbergh; Alexander Hapfelmeier; Bernd Saugel
Journal:  J Clin Monit Comput       Date:  2019-01-03       Impact factor: 2.502

8.  Improved Outcomes of Enhanced Recovery After Surgery (ERAS) Protocol for Radical Cystectomy with Addition of a Multidisciplinary Care Process in a US Comprehensive Cancer Care Center.

Authors:  Sephalie Y Patel; Rosemarie E Garcia Getting; Brandon Alford; Karim Hussein; Braydon J Schaible; David Boulware; Jae K Lee; Scott M Gilbert; Julio M Powsang; Wade J Sexton; Philippe E Spiess; Michael A Poch
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

9.  Automated, continuous and non-invasive assessment of pulse pressure variations using CNAP® system.

Authors:  Matthieu Biais; Laurent Stecken; Aurélie Martin; Stéphanie Roullet; Alice Quinart; François Sztark
Journal:  J Clin Monit Comput       Date:  2016-06-16       Impact factor: 2.502

10.  Perioperative outcomes of goal-directed versus conventional fluid therapy in radical cystectomy with enhanced recovery protocol.

Authors:  Alireza Ghoreifi; Michael F Basin; Saum Ghodoussipour; Soroush T Bazargani; Erfan Amini; Mohammad Aslzare; Jie Cai; Gus Miranda; Shihab Sugeir; Sumeet Bhanvadia; Anne K Schuckman; Siamak Daneshmand; Philip Lumb; Hooman Djaladat
Journal:  Int Urol Nephrol       Date:  2021-06-04       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.